LORATADINE ORAL

LORATADINE ORAL was reported 49838 times

LORATADINE ORAL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN RHINOVIRUS TEST POSITIVE 65 0.1743
1 CARBUNCLE 36 0.1272
2 VIRAL TEST POSITIVE 45 0.1240
3 PNEUMONIA HAEMOPHILUS 53 0.1091
4 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 71 0.1010
5 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 55 0.0518
6 MONOCLONAL IMMUNOGLOBULIN PRESENT 35 0.0461
7 MAST CELL ACTIVATION SYNDROME 63 0.0449
8 NEPHROGENIC ANAEMIA 201 0.0433
9 HYPERPARATHYROIDISM SECONDARY 103 0.0411
10 REBOUND ACID HYPERSECRETION 124 0.0410
11 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 30 0.0336
12 BUTTERFLY RASH 31 0.0306
13 TONGUE BITING 60 0.0291
14 INFUSION SITE DISCHARGE 49 0.0279
15 HYPOTHALAMO-PITUITARY DISORDER 36 0.0247
16 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 125 0.0229
17 ESSENTIAL HYPERTENSION 41 0.0224
18 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 142 0.0209
19 END STAGE RENAL DISEASE 374 0.0205
20 INFUSION SITE PRURITUS 58 0.0184
21 PRE-EXISTING CONDITION IMPROVED 112 0.0179
22 INFUSION SITE HAEMORRHAGE 55 0.0167
23 ASTHMATIC CRISIS 61 0.0167
24 INFUSION SITE INFECTION 38 0.0163
25 CHRONIC KIDNEY DISEASE 1210 0.0159
26 INFUSION SITE SWELLING 97 0.0154
27 FIBROSIS 46 0.0149
28 SEASONAL ALLERGY 208 0.0147
29 PNEUMONIA ASPIRATION 367 0.0147
30 CHRONIC SINUSITIS 54 0.0144
31 RHINITIS ALLERGIC 64 0.0144
32 BACTERIAL TEST POSITIVE 32 0.0143
33 INFUSION SITE PAIN 181 0.0140
34 INFUSION SITE ERYTHEMA 115 0.0136
35 EXPIRED PRODUCT ADMINISTERED 451 0.0136
36 DIABETIC NEUROPATHY 65 0.0131
37 MOUTH HAEMORRHAGE 96 0.0131
38 DEVICE INFUSION ISSUE 31 0.0125
39 PRODUCT ADMINISTRATION INTERRUPTED 98 0.0125
40 PRIAPISM 43 0.0125
41 INFUSION SITE REACTION 36 0.0120
42 RHINOVIRUS INFECTION 45 0.0116
43 LARYNGOSPASM 31 0.0115
44 MULTIPLE ALLERGIES 88 0.0112
45 SNORING 41 0.0108
46 ECONOMIC PROBLEM 160 0.0105
47 RENAL INJURY 313 0.0105
48 DYSPNOEA AT REST 30 0.0103
49 SPINAL OSTEOARTHRITIS 90 0.0102
50 DYSLIPIDAEMIA 52 0.0102
51 PHARYNGEAL SWELLING 99 0.0101
52 RALES 58 0.0100
53 FEELING DRUNK 73 0.0098
54 SOMNAMBULISM 64 0.0097
55 CYSTIC FIBROSIS 53 0.0096
56 OVERWEIGHT 51 0.0095
57 PERIORBITAL OEDEMA 49 0.0094
58 VITAMIN D DEFICIENCY 92 0.0094
59 CHOLECYSTITIS CHRONIC 63 0.0094
60 GASTROOESOPHAGEAL REFLUX DISEASE 756 0.0094
61 RENAL CYST 74 0.0093
62 PROTEIN TOTAL DECREASED 35 0.0093
63 IMPAIRED QUALITY OF LIFE 133 0.0092
64 NEPHROPATHY 86 0.0092
65 SLEEP APNOEA SYNDROME 173 0.0091
66 OSTEOPENIA 137 0.0090
67 MOUTH SWELLING 52 0.0090
68 PARANASAL SINUS DISCOMFORT 33 0.0087
69 HYPERVOLAEMIA 43 0.0087
70 DIZZINESS POSTURAL 84 0.0087
71 POST-TRAUMATIC STRESS DISORDER 58 0.0086
72 ANHEDONIA 224 0.0085
73 HYPERLIPIDAEMIA 100 0.0084
74 PSYCHOLOGICAL TRAUMA 72 0.0083
75 UPPER RESPIRATORY TRACT INFECTION 380 0.0082
76 OROPHARYNGEAL DISCOMFORT 74 0.0082
77 FINGER DEFORMITY 39 0.0080
78 OBSTRUCTIVE AIRWAYS DISORDER 89 0.0080
79 INTERVERTEBRAL DISC DEGENERATION 74 0.0080
80 ENURESIS 32 0.0079
81 TENSION HEADACHE 34 0.0079
82 GRANULOCYTOPENIA 45 0.0079
83 LIP SWELLING 263 0.0079
84 HAEMOGLOBIN INCREASED 36 0.0079
85 UPPER-AIRWAY COUGH SYNDROME 65 0.0079
86 RHINITIS 63 0.0078
87 NASAL DRYNESS 48 0.0077
88 SINUS DISORDER 150 0.0076
89 SKIN WARM 44 0.0076
90 COMA 354 0.0074
91 TUBULOINTERSTITIAL NEPHRITIS 139 0.0074
92 SINUS HEADACHE 44 0.0074
93 FOOD ALLERGY 57 0.0074
94 FEELING OF DESPAIR 34 0.0073
95 INCORRECT DRUG ADMINISTRATION RATE 31 0.0073
96 EXTRA DOSE ADMINISTERED 295 0.0073
97 TEARFULNESS 31 0.0072
98 DRY THROAT 73 0.0072
99 HIATUS HERNIA 92 0.0071
100 DIVERTICULUM INTESTINAL 31 0.0071
101 RENAL FAILURE 936 0.0070
102 IMPAIRED GASTRIC EMPTYING 96 0.0070
103 TORSADE DE POINTES 55 0.0070
104 SWELLING OF EYELID 44 0.0070
105 MAJOR DEPRESSION 51 0.0070
106 OBSESSIVE-COMPULSIVE DISORDER 56 0.0070
107 PAPULE 49 0.0069
108 BLOOD MAGNESIUM DECREASED 60 0.0069
109 DERMATITIS CONTACT 79 0.0069
110 CYTOKINE RELEASE SYNDROME 138 0.0069
111 ASTHMA 775 0.0068
112 EAR INFECTION 182 0.0068
113 MENISCUS INJURY 42 0.0068
114 WHEEZING 405 0.0068
115 BODY HEIGHT DECREASED 73 0.0068
116 SNEEZING 153 0.0068
117 SINUS CONGESTION 92 0.0068
118 SKIN ABRASION 32 0.0068
119 OSTEOPOROSIS 278 0.0068
120 SPUTUM DISCOLOURED 64 0.0067
121 SOMNOLENCE 1353 0.0067
122 LEFT VENTRICULAR DYSFUNCTION 45 0.0067
123 SWELLING FACE 437 0.0067
124 ACUTE KIDNEY INJURY 1022 0.0067
125 LIGAMENT SPRAIN 66 0.0067
126 WALKING AID USER 44 0.0067
127 HEAD DISCOMFORT 118 0.0067
128 TENDERNESS 69 0.0066
129 ANGIOEDEMA 292 0.0066
130 SINUSITIS 675 0.0066
131 BRUXISM 35 0.0065
132 SMALL INTESTINAL OBSTRUCTION 79 0.0064
133 PRODUCTIVE COUGH 306 0.0064
134 ANKLE FRACTURE 99 0.0064
135 EAR PAIN 124 0.0064
136 SLUGGISHNESS 65 0.0064
137 SENSITIVE SKIN 47 0.0064
138 WRONG PRODUCT ADMINISTERED 43 0.0064
139 CARPAL TUNNEL SYNDROME 89 0.0063
140 EAR DISCOMFORT 65 0.0063
141 RHINORRHOEA 409 0.0063
142 RENAL TUBULAR NECROSIS 62 0.0063
143 VIRAL UPPER RESPIRATORY TRACT INFECTION 30 0.0063
144 FEBRILE NEUTROPENIA 417 0.0063
145 SWOLLEN TONGUE 196 0.0063
146 INFUSION SITE EXTRAVASATION 39 0.0063
147 SCRATCH 66 0.0063
148 NASAL CONGESTION 366 0.0062
149 HEPATIC STEATOSIS 116 0.0062
150 OBESITY 99 0.0062
151 PRODUCT TASTE ABNORMAL 84 0.0062
152 OSTEOARTHRITIS 262 0.0062
153 RESTLESS LEGS SYNDROME 112 0.0062
154 SCOLIOSIS 38 0.0061
155 LACRIMATION INCREASED 185 0.0061
156 SENSORY LOSS 49 0.0061
157 HAND FRACTURE 43 0.0061
158 HAIR DISORDER 50 0.0061
159 NASAL DISCOMFORT 48 0.0060
160 JOINT RANGE OF MOTION DECREASED 81 0.0060
161 VARICOSE VEIN 31 0.0060
162 PHOTOSENSITIVITY REACTION 99 0.0060
163 SKIN SWELLING 52 0.0060
164 THROAT TIGHTNESS 162 0.0060
165 ANAPHYLACTIC REACTION 330 0.0060
166 THROAT IRRITATION 267 0.0059
167 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 101 0.0059
168 ORAL CANDIDIASIS 78 0.0059
169 ATELECTASIS 57 0.0059
170 BIPOLAR DISORDER 64 0.0059
171 ACUTE RESPIRATORY FAILURE 113 0.0059
172 FLANK PAIN 55 0.0059
173 IRON DEFICIENCY ANAEMIA 54 0.0058
174 INITIAL INSOMNIA 60 0.0058
175 SCIATICA 93 0.0058
176 BLOOD POTASSIUM DECREASED 175 0.0058
177 BRAIN FOG 91 0.0058
178 GASTROINTESTINAL INFECTION 52 0.0058
179 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 51 0.0058
180 DYSPNOEA EXERTIONAL 217 0.0058
181 GASTROENTERITIS VIRAL 104 0.0058
182 AUTOIMMUNE HEPATITIS 40 0.0057
183 GLUCOSE TOLERANCE IMPAIRED 34 0.0057
184 EXERCISE TOLERANCE DECREASED 33 0.0057
185 BRONCHITIS 424 0.0057
186 TEMPERATURE INTOLERANCE 59 0.0057
187 HAIR COLOUR CHANGES 71 0.0057
188 ORAL DISCOMFORT 79 0.0057
189 CONCUSSION 44 0.0057
190 CELLULITIS 286 0.0057
191 RESPIRATORY TRACT CONGESTION 90 0.0057
192 PERIORBITAL SWELLING 32 0.0057
193 URTICARIA 948 0.0057
194 GALLBLADDER DISORDER 101 0.0057
195 COUGH 1585 0.0056
196 POLYP 37 0.0056
197 DECUBITUS ULCER 46 0.0056
198 CHEST DISCOMFORT 578 0.0056
199 FOOT FRACTURE 107 0.0056
200 SQUAMOUS CELL CARCINOMA OF SKIN 34 0.0056
201 OXYGEN SATURATION DECREASED 316 0.0056
202 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 293 0.0056
203 FULL BLOOD COUNT DECREASED 113 0.0056
204 ENERGY INCREASED 33 0.0056
205 SECRETION DISCHARGE 70 0.0056
206 EXOSTOSIS 51 0.0056
207 DRY MOUTH 453 0.0056
208 HEART RATE IRREGULAR 126 0.0056
209 PSYCHIATRIC SYMPTOM 41 0.0055
210 PURPURA 49 0.0055
211 ROTATOR CUFF SYNDROME 71 0.0055
212 ODYNOPHAGIA 33 0.0055
213 ACCIDENTAL OVERDOSE 201 0.0055
214 ASPIRATION 60 0.0055
215 HYPOMAGNESAEMIA 76 0.0055
216 ASTHENOPIA 30 0.0055
217 PHARYNGITIS STREPTOCOCCAL 59 0.0054
218 LIMB INJURY 148 0.0054
219 MUSCLE STRAIN 47 0.0054
220 MUSCLE TIGHTNESS 88 0.0054
221 ABNORMAL LOSS OF WEIGHT 37 0.0054
222 HYPOXIA 191 0.0054
223 MUSCULOSKELETAL DISCOMFORT 93 0.0054
224 BRONCHOSPASM 77 0.0054
225 OROPHARYNGEAL PAIN 499 0.0054
226 FULL BLOOD COUNT ABNORMAL 57 0.0054
227 WRONG DRUG ADMINISTERED 48 0.0054
228 ANAL ABSCESS 29 0.0054
229 NOCTURIA 65 0.0053
230 BLOOD POTASSIUM INCREASED 86 0.0053
231 BLOOD ALBUMIN DECREASED 42 0.0053
232 HEART RATE INCREASED 524 0.0053
233 TRICUSPID VALVE INCOMPETENCE 42 0.0053
234 RENAL PAIN 56 0.0053
235 DRUG EFFECT LESS THAN EXPECTED 78 0.0053
236 RESPIRATORY TRACT INFECTION 137 0.0053
237 SKIN INFECTION 59 0.0053
238 FEELING COLD 146 0.0052
239 INTERVERTEBRAL DISC PROTRUSION 114 0.0052
240 PHOTOPHOBIA 98 0.0052
241 SALIVARY HYPERSECRETION 52 0.0052
242 CHOLELITHIASIS 170 0.0052
243 PSYCHOMOTOR HYPERACTIVITY 86 0.0052
244 HYPERVENTILATION 30 0.0052
245 MADAROSIS 60 0.0052
246 MUSCULOSKELETAL CHEST PAIN 80 0.0052
247 RESPIRATORY SYNCYTIAL VIRUS INFECTION 45 0.0052
248 EPISTAXIS 386 0.0052
249 STRESS CARDIOMYOPATHY 30 0.0052
250 FACE OEDEMA 87 0.0052
251 FACIAL PAIN 46 0.0051
252 MENTAL STATUS CHANGES 143 0.0051
253 VITAMIN D DECREASED 44 0.0051
254 LETHARGY 296 0.0051
255 FOOT DEFORMITY 57 0.0051
256 DEFAECATION URGENCY 36 0.0051
257 ORAL PAIN 115 0.0051
258 VENTRICULAR FIBRILLATION 57 0.0051
259 PARAESTHESIA ORAL 74 0.0051
260 GOUT 92 0.0051
261 HYPOVOLAEMIA 30 0.0051
262 DERMATITIS BULLOUS 37 0.0051
263 RASH PRURITIC 277 0.0051
264 PALPITATIONS 598 0.0051
265 ELECTROCARDIOGRAM ABNORMAL 40 0.0051
266 HYPERSOMNIA 146 0.0051
267 BOWEL MOVEMENT IRREGULARITY 39 0.0051
268 NIGHT SWEATS 164 0.0051
269 VITREOUS FLOATERS 50 0.0051
270 GENERALISED TONIC-CLONIC SEIZURE 84 0.0051
271 HAEMORRHOIDS 99 0.0051
272 TOXIC EPIDERMAL NECROLYSIS 77 0.0051
273 HYPOAESTHESIA ORAL 76 0.0050
274 RED BLOOD CELL COUNT DECREASED 144 0.0050
275 POOR QUALITY SLEEP 108 0.0050
276 CEREBRAL DISORDER 37 0.0050
277 QUALITY OF LIFE DECREASED 67 0.0050
278 ARTHROPOD BITE 37 0.0050
279 MICTURITION URGENCY 57 0.0050
280 LIMB DISCOMFORT 154 0.0050
281 INSURANCE ISSUE 76 0.0050
282 EYE PRURITUS 167 0.0050
283 HOSPICE CARE 49 0.0050
284 CHOLECYSTITIS 59 0.0049
285 FLUID OVERLOAD 72 0.0049
286 PHARYNGEAL OEDEMA 76 0.0049
287 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 271 0.0049
288 NEURALGIA 120 0.0049
289 HAIR TEXTURE ABNORMAL 66 0.0049
290 JOINT EFFUSION 34 0.0049
291 DIVERTICULUM 35 0.0049
292 EYELID OEDEMA 57 0.0049
293 PNEUMONIA BACTERIAL 45 0.0049
294 ANAL INCONTINENCE 44 0.0049
295 SLEEP DISORDER 345 0.0049
296 MIDDLE INSOMNIA 91 0.0049
297 URINARY TRACT INFECTION 831 0.0049
298 SCREAMING 31 0.0049
299 DYSSTASIA 142 0.0049
300 SKIN HAEMORRHAGE 72 0.0049
301 PNEUMONIA 1570 0.0048
302 FEELING HOT 297 0.0048
303 RESPIRATORY RATE INCREASED 43 0.0048
304 ANXIETY 1378 0.0048
305 DYSPHONIA 283 0.0048
306 PHARYNGITIS 60 0.0048
307 BONE DISORDER 88 0.0048
308 DECREASED ACTIVITY 52 0.0048
309 BONE DENSITY DECREASED 151 0.0048
310 VENTRICULAR EXTRASYSTOLES 50 0.0048
311 LYMPHOCYTE COUNT DECREASED 85 0.0048
312 RASH MACULAR 168 0.0048
313 CHEST PAIN 889 0.0048
314 BACK DISORDER 78 0.0048
315 DECREASED IMMUNE RESPONSIVENESS 47 0.0048
316 EYE SWELLING 178 0.0048
317 TENDONITIS 74 0.0048
318 DROOLING 33 0.0048
319 FEELING JITTERY 91 0.0048
320 UROSEPSIS 44 0.0048
321 NERVE COMPRESSION 44 0.0048
322 NECK PAIN 266 0.0048
323 INFUSION RELATED REACTION 315 0.0047
324 THERAPEUTIC RESPONSE UNEXPECTED 213 0.0047
325 PANIC ATTACK 173 0.0047
326 LOWER GASTROINTESTINAL HAEMORRHAGE 35 0.0047
327 TINNITUS 217 0.0047
328 BLOOD CALCIUM DECREASED 53 0.0047
329 GASTRITIS 124 0.0047
330 AFFECTIVE DISORDER 37 0.0047
331 FRUSTRATION TOLERANCE DECREASED 38 0.0047
332 DYSARTHRIA 177 0.0047
333 FLUID RETENTION 239 0.0047
334 PRODUCT DOSE OMISSION IN ERROR 133 0.0047
335 TYPE 2 DIABETES MELLITUS 158 0.0047
336 RETCHING 100 0.0047
337 HAEMATOCRIT DECREASED 93 0.0047
338 DEPRESSION 1065 0.0047
339 PULMONARY THROMBOSIS 51 0.0047
340 BLOOD PRESSURE ABNORMAL 93 0.0047
341 BONE PAIN 274 0.0047
342 EYE MOVEMENT DISORDER 32 0.0047
343 PRURITUS GENERALISED 101 0.0047
344 RIB FRACTURE 96 0.0047
345 THERMAL BURN 33 0.0046
346 PRODUCT DISTRIBUTION ISSUE 43 0.0046
347 CONJUNCTIVITIS 86 0.0046
348 BLOOD IRON DECREASED 55 0.0046
349 INCOHERENT 30 0.0046
350 PERIPHERAL SWELLING 714 0.0046
351 PNEUMONITIS 126 0.0046
352 HYPOKALAEMIA 213 0.0046
353 DENTAL CARIES 51 0.0046
354 CONSTIPATION 997 0.0046
355 RIGHT VENTRICULAR FAILURE 32 0.0046
356 COVID-19 801 0.0046
357 MULTIPLE FRACTURES 75 0.0046
358 PULMONARY HYPERTENSION 95 0.0046
359 PULMONARY ARTERIAL HYPERTENSION 66 0.0046
360 CHOLECYSTECTOMY 52 0.0045
361 DIVERTICULITIS 126 0.0045
362 SPINAL DISORDER 43 0.0045
363 NEPHROLITHIASIS 208 0.0045
364 NEUROPATHY PERIPHERAL 431 0.0045
365 DERMATITIS ALLERGIC 57 0.0045
366 ATRIOVENTRICULAR BLOCK 35 0.0045
367 HUNGER 63 0.0045
368 SKIN LESION 124 0.0045
369 UTERINE LEIOMYOMA 33 0.0045
370 HOT FLUSH 340 0.0045
371 DYSURIA 166 0.0045
372 ORAL HERPES 88 0.0045
373 CARDIAC MURMUR 39 0.0045
374 EYE INFLAMMATION 43 0.0045
375 HYSTERECTOMY 39 0.0045
376 BACK PAIN 1045 0.0045
377 SKIN DISORDER 150 0.0045
378 CHILLS 527 0.0045
379 DYSPNOEA 2542 0.0045
380 DISTURBANCE IN ATTENTION 242 0.0045
381 INFLUENZA 500 0.0045
382 PRESYNCOPE 109 0.0045
383 AGITATION 329 0.0045
384 DEPRESSED MOOD 236 0.0045
385 MYASTHENIA GRAVIS 36 0.0045
386 DERMATITIS ATOPIC 235 0.0045
387 BLOOD SODIUM DECREASED 84 0.0045
388 INCREASED TENDENCY TO BRUISE 41 0.0045
389 NIGHTMARE 154 0.0044
390 DRY EYE 222 0.0044
391 DYSPEPSIA 437 0.0044
392 EOSINOPHIL COUNT INCREASED 37 0.0044
393 RASH ERYTHEMATOUS 212 0.0044
394 SYNCOPE 443 0.0044
395 SENSORY DISTURBANCE 71 0.0044
396 INSOMNIA 1178 0.0044
397 BLOOD CHOLESTEROL INCREASED 206 0.0044
398 SKIN LACERATION 48 0.0044
399 BLOOD PRESSURE INCREASED 673 0.0044
400 MIGRAINE 420 0.0044
401 TOOTH INFECTION 58 0.0044
402 ILLNESS 453 0.0044
403 WEIGHT FLUCTUATION 46 0.0044
404 EYE PAIN 248 0.0044
405 EUPHORIC MOOD 45 0.0044
406 VIRAL INFECTION 146 0.0044
407 HICCUPS 36 0.0044
408 HYPERSENSITIVITY 813 0.0044
409 THIRST 78 0.0044
410 IMMUNODEFICIENCY 65 0.0044
411 CHOKING 85 0.0044
412 SPLENOMEGALY 51 0.0043
413 BALANCE DISORDER 376 0.0043
414 DIZZINESS 2169 0.0043
415 LOCALISED INFECTION 105 0.0043
416 FATIGUE 3380 0.0043
417 LYMPHOEDEMA 30 0.0043
418 WRIST FRACTURE 52 0.0043
419 MUSCLE SPASMS 796 0.0043
420 ABNORMAL DREAMS 119 0.0043
421 VENTRICULAR TACHYCARDIA 71 0.0043
422 MUSCULOSKELETAL PAIN 225 0.0043
423 HYPOTHYROIDISM 137 0.0043
424 ARTHRITIS 337 0.0043
425 JOINT STIFFNESS 112 0.0043
426 TOOTHACHE 77 0.0042
427 SARS-COV-2 TEST POSITIVE 56 0.0042
428 COVID-19 PNEUMONIA 50 0.0042
429 EYE DISCHARGE 44 0.0042
430 PULMONARY MASS 63 0.0042
431 BURSITIS 51 0.0042
432 PAIN IN JAW 119 0.0042
433 FLUSHING 427 0.0042
434 NEUTROPHIL COUNT INCREASED 43 0.0042
435 PSEUDOMONAS INFECTION 36 0.0042
436 BLOOD ALKALINE PHOSPHATASE INCREASED 104 0.0042
437 THINKING ABNORMAL 78 0.0042
438 ERYTHEMA MULTIFORME 39 0.0042
439 DEHYDRATION 557 0.0042
440 PRURITUS 1604 0.0042
441 CRYING 151 0.0042
442 WHITE BLOOD CELL COUNT DECREASED 450 0.0041
443 MASS 58 0.0041
444 ELECTROLYTE IMBALANCE 48 0.0041
445 BLADDER DISORDER 41 0.0041
446 HAEMOPTYSIS 115 0.0041
447 SCAB 47 0.0041
448 FIBROMYALGIA 100 0.0041
449 TRANSFUSION 43 0.0041
450 GRIP STRENGTH DECREASED 36 0.0041
451 BLOOD COUNT ABNORMAL 62 0.0041
452 COORDINATION ABNORMAL 57 0.0041
453 VISION BLURRED 561 0.0041
454 SUPRAVENTRICULAR TACHYCARDIA 39 0.0041
455 BODY TEMPERATURE DECREASED 40 0.0041
456 INTENTIONAL SELF-INJURY 82 0.0041
457 OEDEMA 220 0.0041
458 DERMATITIS 85 0.0041
459 GASTRIC ULCER 77 0.0040
460 HYPOTHERMIA 41 0.0040
461 FLATULENCE 229 0.0040
462 ATRIAL FIBRILLATION 393 0.0040
463 CHROMATURIA 91 0.0040
464 NASOPHARYNGITIS 743 0.0040
465 ABDOMINAL DISCOMFORT 676 0.0040
466 JOINT INJURY 86 0.0040
467 HEADACHE 2518 0.0040
468 RESPIRATORY DISORDER 120 0.0040
469 ABDOMINAL PAIN UPPER 825 0.0040
470 STOMATITIS 243 0.0040
471 DRUG ERUPTION 71 0.0040
472 PARANOIA 69 0.0040
473 RASH MACULO-PAPULAR 89 0.0040
474 TOOTH FRACTURE 44 0.0040
475 FUNGAL INFECTION 133 0.0040
476 INFLAMMATORY BOWEL DISEASE 39 0.0040
477 DYSKINESIA 162 0.0040
478 CARDIOMEGALY 49 0.0040
479 PERSONALITY CHANGE 37 0.0040
480 OEDEMA PERIPHERAL 485 0.0040
481 BLISTER 223 0.0040
482 ABDOMINAL DISTENSION 414 0.0040
483 AMNESIA 257 0.0039
484 PULMONARY CONGESTION 52 0.0039
485 APHONIA 55 0.0039
486 MOUTH ULCERATION 83 0.0039
487 ACUTE MYOCARDIAL INFARCTION 116 0.0039
488 POLLAKIURIA 164 0.0039
489 SUICIDAL IDEATION 360 0.0039
490 HYPOAESTHESIA 588 0.0039
491 TOOTH ABSCESS 40 0.0039
492 CYSTITIS 125 0.0039
493 HEAD INJURY 124 0.0039
494 BACTERIAL INFECTION 73 0.0039
495 HYPERHIDROSIS 504 0.0039
496 ASTHENIA 1471 0.0039
497 DISCOMFORT 238 0.0039
498 EATING DISORDER 83 0.0039
499 ALANINE AMINOTRANSFERASE INCREASED 239 0.0039
500 PARAESTHESIA 612 0.0039
501 HYPERTENSION 824 0.0039
502 SKIN FISSURES 76 0.0039
503 PAIN IN EXTREMITY 1144 0.0039
504 BLOOD UREA INCREASED 65 0.0039
505 BURNING SENSATION 272 0.0039
506 SINUS TACHYCARDIA 55 0.0039
507 BODY TEMPERATURE INCREASED 79 0.0039
508 IMPAIRED DRIVING ABILITY 44 0.0039
509 MUSCLE TWITCHING 89 0.0039
510 COLD SWEAT 68 0.0039
511 DIABETES MELLITUS 294 0.0039
512 RASH 1681 0.0039
513 MOOD ALTERED 105 0.0038
514 FALL 1281 0.0038
515 URINARY INCONTINENCE 114 0.0038
516 FEEDING DISORDER 78 0.0038
517 CONTUSION 370 0.0038
518 DIABETES MELLITUS INADEQUATE CONTROL 68 0.0038
519 PETECHIAE 40 0.0038
520 DIARRHOEA 2471 0.0038
521 IRRITABLE BOWEL SYNDROME 82 0.0038
522 STEVENS-JOHNSON SYNDROME 85 0.0038
523 KIDNEY INFECTION 75 0.0038
524 SWELLING 357 0.0038
525 EYE INFECTION 43 0.0038
526 NEUTROPHIL COUNT DECREASED 155 0.0038
527 MITRAL VALVE INCOMPETENCE 43 0.0038
528 SCAR 65 0.0038
529 DRUG SCREEN POSITIVE 30 0.0038
530 CANDIDA INFECTION 64 0.0038
531 INCONTINENCE 40 0.0038
532 COAGULOPATHY 63 0.0038
533 VASCULITIS 44 0.0038
534 RESPIRATORY FAILURE 275 0.0038
535 DEVICE RELATED INFECTION 58 0.0038
536 UPPER LIMB FRACTURE 75 0.0038
537 INJECTION SITE DISCOLOURATION 47 0.0038
538 ATRIAL FLUTTER 30 0.0038
539 GROIN PAIN 33 0.0038
540 OESOPHAGITIS 41 0.0037
541 FEELING ABNORMAL 898 0.0037
542 TASTE DISORDER 76 0.0037
543 ARTHROPATHY 208 0.0037
544 OCULAR DISCOMFORT 42 0.0037
545 MOOD SWINGS 119 0.0037
546 CONFUSIONAL STATE 603 0.0037
547 TREMOR 619 0.0037
548 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 179 0.0037
549 TACHYCARDIA 331 0.0037
550 ARTERIOSCLEROSIS 35 0.0037
551 DYSGEUSIA 276 0.0037
552 PYREXIA 1283 0.0037
553 SEPSIS 413 0.0037
554 GASTROENTERITIS 54 0.0037
555 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 263 0.0037
556 HALLUCINATION 278 0.0037
557 INTENTIONAL OVERDOSE 236 0.0037
558 MALNUTRITION 41 0.0037
559 WEIGHT INCREASED 819 0.0037
560 ECZEMA 191 0.0036
561 ESCHERICHIA INFECTION 30 0.0036
562 TOOTH DISORDER 81 0.0036
563 PERIPHERAL COLDNESS 50 0.0036
564 TUMOUR LYSIS SYNDROME 32 0.0036
565 SKIN DISCOLOURATION 167 0.0036
566 LIP DRY 33 0.0036
567 MYALGIA 617 0.0036
568 SPINAL COMPRESSION FRACTURE 30 0.0036
569 IMMUNOSUPPRESSION 32 0.0036
570 AGGRESSION 181 0.0036
571 ANGER 122 0.0036
572 PLATELET COUNT INCREASED 47 0.0036
573 MEMORY IMPAIRMENT 495 0.0036
574 BLOOD PRESSURE DECREASED 239 0.0036
575 URINARY RETENTION 120 0.0036
576 DECREASED APPETITE 834 0.0036
577 GASTROINTESTINAL HAEMORRHAGE 300 0.0036
578 SPEECH DISORDER 188 0.0036
579 BLOOD THYROID STIMULATING HORMONE INCREASED 33 0.0036
580 ACUTE HEPATIC FAILURE 49 0.0036
581 ARTHRALGIA 1489 0.0036
582 GAIT DISTURBANCE 685 0.0036
583 IRRITABILITY 215 0.0036
584 THERAPEUTIC PRODUCT EFFECT DECREASED 160 0.0036
585 FEAR 96 0.0036
586 HYPONATRAEMIA 201 0.0036
587 UPPER GASTROINTESTINAL HAEMORRHAGE 60 0.0036
588 IMMUNE SYSTEM DISORDER 47 0.0036
589 SENSATION OF FOREIGN BODY 30 0.0036
590 BLOOD TEST ABNORMAL 50 0.0036
591 NAUSEA 2816 0.0036
592 WEIGHT DECREASED 993 0.0036
593 DRUG INTERACTION 564 0.0036
594 GASTRIC DISORDER 122 0.0036
595 RASH GENERALISED 92 0.0035
596 FAECES DISCOLOURED 77 0.0035
597 ADRENAL INSUFFICIENCY 43 0.0035
598 RENAL DISORDER 165 0.0035
599 NERVOUSNESS 185 0.0035
600 ABNORMAL FAECES 29 0.0035
601 CORONARY ARTERY DISEASE 107 0.0035
602 TACHYPNOEA 48 0.0035
603 PLATELET COUNT DECREASED 376 0.0035
604 UNRESPONSIVE TO STIMULI 91 0.0035
605 ANOSMIA 51 0.0035
606 HYPOPHAGIA 90 0.0035
607 MOVEMENT DISORDER 113 0.0035
608 CONDITION AGGRAVATED 1068 0.0035
609 HAEMATOMA 91 0.0035
610 SPINAL PAIN 41 0.0035
611 TRANSIENT ISCHAEMIC ATTACK 118 0.0035
612 SURGERY 205 0.0035
613 BACK INJURY 38 0.0035
614 CLOSTRIDIUM DIFFICILE COLITIS 37 0.0035
615 ASPARTATE AMINOTRANSFERASE INCREASED 185 0.0035
616 LOSS OF CONSCIOUSNESS 446 0.0035
617 MUSCLE ATROPHY 44 0.0035
618 BREAST PAIN 37 0.0035
619 DIPLOPIA 90 0.0035
620 LABORATORY TEST ABNORMAL 102 0.0035
621 STAPHYLOCOCCAL INFECTION 114 0.0035
622 BACTERAEMIA 41 0.0035
623 EYE HAEMORRHAGE 46 0.0034
624 VERTIGO 210 0.0034
625 GAIT INABILITY 115 0.0034
626 WHITE BLOOD CELL COUNT INCREASED 132 0.0034
627 EMOTIONAL DISORDER 106 0.0034
628 BLOOD PRESSURE SYSTOLIC INCREASED 67 0.0034
629 HEPATIC ENZYME INCREASED 234 0.0034
630 MYDRIASIS 44 0.0034
631 SEIZURE 396 0.0034
632 CORONARY ARTERY OCCLUSION 47 0.0034
633 HYPERCHOLESTEROLAEMIA 33 0.0034
634 BLOOD PRESSURE FLUCTUATION 82 0.0034
635 DELUSION 53 0.0034
636 ERYTHEMA 700 0.0034
637 GENERALISED OEDEMA 42 0.0034
638 ACTIVITIES OF DAILY LIVING IMPAIRED 67 0.0034
639 ILEUS 42 0.0034
640 CARDIAC FAILURE CONGESTIVE 271 0.0034
641 BLOOD URINE PRESENT 64 0.0034
642 LEUKOCYTOSIS 61 0.0034
643 INTERNATIONAL NORMALISED RATIO INCREASED 96 0.0034
644 GASTROINTESTINAL PAIN 37 0.0034
645 MUSCULAR WEAKNESS 382 0.0034
646 HAEMOGLOBIN DECREASED 345 0.0034
647 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 86 0.0033
648 PAIN 2047 0.0033
649 ABNORMAL BEHAVIOUR 132 0.0033
650 HYPOTENSION 668 0.0033
651 JOINT SWELLING 401 0.0033
652 SKIN EXFOLIATION 280 0.0033
653 DYSPHAGIA 315 0.0033
654 EYE DISORDER 109 0.0033
655 INFLAMMATION 171 0.0033
656 LYMPHADENOPATHY 117 0.0033
657 ABDOMINAL PAIN 766 0.0033
658 AGEUSIA 82 0.0033
659 PLEURAL EFFUSION 200 0.0033
660 ABDOMINAL PAIN LOWER 83 0.0033
661 VOMITING 1540 0.0033
662 CATARACT 195 0.0033
663 ORTHOSTATIC HYPOTENSION 57 0.0033
664 BASAL CELL CARCINOMA 51 0.0033
665 EYE IRRITATION 188 0.0033
666 RECTAL HAEMORRHAGE 140 0.0033
667 EMOTIONAL DISTRESS 394 0.0033
668 CLOSTRIDIUM DIFFICILE INFECTION 71 0.0032
669 RESTLESSNESS 119 0.0032
670 DRUG-INDUCED LIVER INJURY 102 0.0032
671 COGNITIVE DISORDER 151 0.0032
672 LIVER FUNCTION TEST ABNORMAL 94 0.0032
673 INTENTIONAL DOSE OMISSION 92 0.0032
674 CYST 40 0.0032
675 BLOOD BILIRUBIN INCREASED 87 0.0032
676 PRODUCT DOSE OMISSION ISSUE 947 0.0032
677 EJECTION FRACTION DECREASED 50 0.0032
678 TOOTH EXTRACTION 40 0.0032
679 UNEVALUABLE EVENT 243 0.0032
680 MUSCULOSKELETAL STIFFNESS 281 0.0032
681 GAMMA-GLUTAMYLTRANSFERASE INCREASED 71 0.0032
682 SUICIDE ATTEMPT 194 0.0032
683 HAEMATEMESIS 81 0.0032
684 LACERATION 30 0.0032
685 POOR VENOUS ACCESS 33 0.0032
686 LOWER RESPIRATORY TRACT INFECTION 145 0.0032
687 THYROID DISORDER 49 0.0032
688 INFLUENZA LIKE ILLNESS 261 0.0032
689 BLOOD CREATININE INCREASED 207 0.0032
690 BLOOD TRIGLYCERIDES INCREASED 56 0.0032
691 GLAUCOMA 61 0.0032
692 MANIA 52 0.0032
693 DEEP VEIN THROMBOSIS 205 0.0032
694 HEPATOMEGALY 31 0.0032
695 MENTAL DISORDER 137 0.0031
696 OCULAR HYPERAEMIA 149 0.0031
697 PULMONARY EMBOLISM 298 0.0031
698 MENTAL IMPAIRMENT 76 0.0031
699 HYPERGLYCAEMIA 114 0.0031
700 HALLUCINATION, VISUAL 66 0.0031
701 ERUCTATION 60 0.0031
702 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 53 0.0031
703 INJURY 217 0.0031
704 TOOTH LOSS 64 0.0031
705 ELECTROCARDIOGRAM QT PROLONGED 111 0.0031
706 MALAISE 1352 0.0031
707 HIP FRACTURE 99 0.0031
708 EMPHYSEMA 31 0.0031
709 POST PROCEDURAL COMPLICATION 59 0.0031
710 INJECTION SITE RASH 94 0.0031
711 SEDATION 80 0.0031
712 HERNIA 59 0.0030
713 PRESCRIBED OVERDOSE 59 0.0030
714 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 549 0.0030
715 CARDIOMYOPATHY 45 0.0030
716 RESPIRATORY DISTRESS 84 0.0030
717 RASH PAPULAR 68 0.0030
718 ATAXIA 36 0.0030
719 PERICARDIAL EFFUSION 70 0.0030
720 JOINT DISLOCATION 32 0.0030
721 THERAPY CESSATION 155 0.0030
722 SEPTIC SHOCK 131 0.0030
723 LUNG DISORDER 147 0.0030
724 PULMONARY OEDEMA 134 0.0030
725 INFECTION 432 0.0030
726 OSTEOMYELITIS 54 0.0030
727 TREATMENT NONCOMPLIANCE 163 0.0030
728 AUTOIMMUNE DISORDER 29 0.0030
729 NERVE INJURY 33 0.0030
730 ANAEMIA 566 0.0030
731 HEART RATE DECREASED 104 0.0030
732 VISUAL IMPAIRMENT 367 0.0030
733 ULCER 47 0.0030
734 HERPES ZOSTER 169 0.0029
735 MUCOSAL INFLAMMATION 77 0.0029
736 INCREASED APPETITE 56 0.0029
737 INTENTIONAL PRODUCT USE ISSUE 256 0.0029
738 WOUND INFECTION 32 0.0029
739 INTESTINAL OBSTRUCTION 110 0.0029
740 COLITIS 110 0.0029
741 THERAPEUTIC RESPONSE DECREASED 174 0.0029
742 PARALYSIS 41 0.0029
743 PELVIC PAIN 52 0.0029
744 THROMBOSIS 230 0.0029
745 PRODUCT USE IN UNAPPROVED INDICATION 708 0.0029
746 HYPOCALCAEMIA 54 0.0029
747 MACULAR DEGENERATION 34 0.0028
748 RENAL IMPAIRMENT 239 0.0028
749 HEMIPARESIS 48 0.0028
750 HALLUCINATION, AUDITORY 45 0.0028
751 LUNG INFECTION 44 0.0028
752 ROAD TRAFFIC ACCIDENT 118 0.0028
753 DISEASE RECURRENCE 134 0.0028
754 BLOOD GLUCOSE ABNORMAL 52 0.0028
755 DRUG INEFFECTIVE 3709 0.0028
756 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 200 0.0028
757 HAEMATURIA 96 0.0028
758 DRUG EFFECT DECREASED 151 0.0028
759 METASTASES TO BONE 46 0.0028
760 DRY SKIN 374 0.0028
761 GASTROINTESTINAL DISORDER 251 0.0028
762 DEAFNESS 73 0.0028
763 METABOLIC ACIDOSIS 89 0.0028
764 DISABILITY 55 0.0028
765 PRODUCT PHYSICAL ISSUE 56 0.0028
766 DISORIENTATION 110 0.0028
767 ALOPECIA 544 0.0028
768 MUSCLE SPASTICITY 34 0.0028
769 ACCIDENT 33 0.0028
770 PSORIATIC ARTHROPATHY 112 0.0028
771 LOWER LIMB FRACTURE 53 0.0028
772 NODULE 36 0.0028
773 PRODUCT DOSE OMISSION 180 0.0028
774 ASCITES 81 0.0028
775 WOUND 77 0.0028
776 CARDIO-RESPIRATORY ARREST 115 0.0027
777 EPILEPSY 84 0.0027
778 ARRHYTHMIA 130 0.0027
779 CYANOSIS 43 0.0027
780 CARDIAC ARREST 225 0.0027
781 GLOSSODYNIA 61 0.0027
782 ANGINA PECTORIS 78 0.0027
783 SYNOVITIS 49 0.0027
784 APHASIA 82 0.0027
785 THERAPY INTERRUPTED 194 0.0027
786 THERAPEUTIC RESPONSE SHORTENED 90 0.0027
787 PNEUMOTHORAX 43 0.0027
788 DEVICE OCCLUSION 38 0.0027
789 NEOPLASM 31 0.0027
790 SPINAL FRACTURE 54 0.0027
791 BLINDNESS UNILATERAL 38 0.0027
792 MOBILITY DECREASED 193 0.0027
793 OFF LABEL USE 2351 0.0027
794 DRUG EFFECT INCOMPLETE 97 0.0027
795 BRADYCARDIA 141 0.0027
796 HEPATITIS 68 0.0027
797 HYPERKALAEMIA 93 0.0026
798 DELIRIUM 92 0.0026
799 MYOCARDIAL ISCHAEMIA 30 0.0026
800 THERAPY PARTIAL RESPONDER 41 0.0026
801 POISONING 33 0.0026
802 PALLOR 71 0.0026
803 LIVER FUNCTION TEST INCREASED 56 0.0026
804 CHOLESTASIS 50 0.0026
805 THERAPY NON-RESPONDER 117 0.0026
806 SPINAL OPERATION 32 0.0026
807 UNDERDOSE 189 0.0026
808 PANCREATITIS ACUTE 58 0.0026
809 LOCAL SWELLING 45 0.0026
810 CONVULSION 147 0.0026
811 INCORRECT DOSE ADMINISTERED 584 0.0026
812 SKIN ULCER 66 0.0026
813 INJECTION SITE WARMTH 52 0.0025
814 MYOCLONUS 30 0.0025
815 SUBDURAL HAEMATOMA 36 0.0025
816 HYPERCALCAEMIA 31 0.0025
817 ANKYLOSING SPONDYLITIS 33 0.0025
818 INCORRECT PRODUCT ADMINISTRATION DURATION 54 0.0025
819 PLASMA CELL MYELOMA 97 0.0025
820 HIP ARTHROPLASTY 38 0.0025
821 LIVER DISORDER 110 0.0025
822 RENAL FAILURE ACUTE 105 0.0025
823 HYPOACUSIS 106 0.0025
824 HOSPITALISATION 378 0.0025
825 COMPLETED SUICIDE 205 0.0025
826 DRUG INTOLERANCE 237 0.0025
827 PSORIASIS 320 0.0024
828 HAEMATOCHEZIA 135 0.0024
829 INJECTION SITE URTICARIA 60 0.0024
830 IMPAIRED HEALING 80 0.0024
831 DEVICE FAILURE 37 0.0024
832 PRODUCT AVAILABILITY ISSUE 55 0.0024
833 PROCEDURAL PAIN 67 0.0024
834 PRODUCT USE COMPLAINT 38 0.0024
835 PANCREATITIS 127 0.0024
836 PRODUCT SUBSTITUTION ISSUE 138 0.0024
837 PROSTATIC SPECIFIC ANTIGEN INCREASED 33 0.0024
838 HEPATIC CIRRHOSIS 45 0.0024
839 ABSCESS 38 0.0024
840 GLYCOSYLATED HAEMOGLOBIN INCREASED 60 0.0024
841 DEPRESSED LEVEL OF CONSCIOUSNESS 94 0.0024
842 NEUTROPENIA 323 0.0024
843 PRODUCT ADMINISTRATION ERROR 48 0.0024
844 KNEE ARTHROPLASTY 50 0.0024
845 INJECTION SITE PRURITUS 159 0.0024
846 DIABETIC KETOACIDOSIS 57 0.0024
847 BEDRIDDEN 31 0.0024
848 RESPIRATORY ARREST 65 0.0024
849 FEMUR FRACTURE 73 0.0024
850 DRUG TOXICITY 32 0.0023
851 PHARMACEUTICAL PRODUCT COMPLAINT 61 0.0023
852 DRUG PRESCRIBING ERROR 45 0.0023
853 COMPLICATION ASSOCIATED WITH DEVICE 34 0.0023
854 MULTIPLE ORGAN DYSFUNCTION SYNDROME 66 0.0023
855 DEMENTIA 65 0.0023
856 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 68 0.0023
857 ENCEPHALOPATHY 57 0.0023
858 HAEMORRHAGE 242 0.0023
859 MUSCULOSKELETAL DISORDER 44 0.0023
860 INJECTION SITE SWELLING 177 0.0023
861 JAUNDICE 62 0.0023
862 LEUKOPENIA 115 0.0023
863 IMPAIRED WORK ABILITY 49 0.0023
864 BLOOD GLUCOSE DECREASED 110 0.0023
865 MULTIPLE SCLEROSIS 109 0.0023
866 PRODUCT USE ISSUE 428 0.0023
867 BONE LOSS 34 0.0023
868 FREQUENT BOWEL MOVEMENTS 61 0.0023
869 PANCYTOPENIA 126 0.0023
870 MALIGNANT MELANOMA 30 0.0022
871 DISEASE PROGRESSION 264 0.0022
872 SKIN CANCER 48 0.0022
873 EOSINOPHILIA 39 0.0022
874 THROMBOCYTOPENIA 248 0.0022
875 DYSTONIA 43 0.0022
876 MULTIPLE SCLEROSIS RELAPSE 151 0.0022
877 PAIN OF SKIN 59 0.0022
878 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 51 0.0022
879 SEROTONIN SYNDROME 42 0.0022
880 PRODUCT PRESCRIBING ERROR 51 0.0021
881 ANAPHYLACTIC SHOCK 55 0.0021
882 CARDIAC FAILURE 171 0.0021
883 INTENTIONAL PRODUCT MISUSE 185 0.0021
884 INJECTION SITE BRUISING 168 0.0021
885 ERECTILE DYSFUNCTION 54 0.0021
886 PSYCHOTIC DISORDER 62 0.0021
887 INJECTION SITE ERYTHEMA 260 0.0021
888 WITHDRAWAL SYNDROME 88 0.0021
889 ILL-DEFINED DISORDER 127 0.0021
890 VISUAL ACUITY REDUCED 69 0.0021
891 INJECTION SITE HAEMATOMA 30 0.0021
892 PRODUCT PRESCRIBING ISSUE 45 0.0021
893 ABASIA 51 0.0021
894 CEREBROVASCULAR ACCIDENT 348 0.0021
895 DRUG ADMINISTRATION ERROR 63 0.0021
896 ADVERSE DRUG REACTION 184 0.0020
897 CARDIAC DISORDER 191 0.0020
898 HYPOGLYCAEMIA 98 0.0020
899 ISCHAEMIC STROKE 36 0.0020
900 BLOOD CREATINE PHOSPHOKINASE INCREASED 58 0.0020
901 PROTEINURIA 38 0.0020
902 ABORTION SPONTANEOUS 80 0.0020
903 TARDIVE DYSKINESIA 56 0.0020
904 VAGINAL HAEMORRHAGE 86 0.0020
905 CARDIOVASCULAR DISORDER 50 0.0020
906 LIVER INJURY 48 0.0020
907 SKIN BURNING SENSATION 140 0.0020
908 LACTIC ACIDOSIS 63 0.0019
909 PERITONITIS 40 0.0019
910 EXPOSURE VIA SKIN CONTACT 50 0.0019
911 MEDICATION ERROR 107 0.0019
912 CEREBRAL INFARCTION 47 0.0019
913 MATERNAL EXPOSURE DURING PREGNANCY 171 0.0019
914 CONTRAINDICATED PRODUCT ADMINISTERED 58 0.0019
915 INJECTION SITE REACTION 131 0.0019
916 PREGNANCY 38 0.0019
917 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 383 0.0019
918 EXPOSURE DURING PREGNANCY 117 0.0019
919 DRUG DOSE OMISSION 310 0.0019
920 BLOOD GLUCOSE INCREASED 353 0.0019
921 SYSTEMIC LUPUS ERYTHEMATOSUS 66 0.0019
922 RHEUMATOID ARTHRITIS 211 0.0019
923 TOXICITY TO VARIOUS AGENTS 312 0.0018
924 DRUG LEVEL INCREASED 30 0.0018
925 FRACTURE 34 0.0018
926 INJECTION SITE PAIN 546 0.0018
927 PRODUCT QUALITY ISSUE 241 0.0018
928 PULMONARY FIBROSIS 34 0.0018
929 ACNE 133 0.0018
930 ALTERED STATE OF CONSCIOUSNESS 38 0.0018
931 OVERDOSE 376 0.0017
932 DEVICE ISSUE 156 0.0017
933 MYOCARDIAL INFARCTION 300 0.0017
934 BLINDNESS 70 0.0017
935 TRANSAMINASES INCREASED 38 0.0017
936 METASTASES TO LIVER 30 0.0017
937 NERVOUS SYSTEM DISORDER 53 0.0017
938 INTERSTITIAL LUNG DISEASE 82 0.0017
939 HEPATIC FUNCTION ABNORMAL 63 0.0017
940 C-REACTIVE PROTEIN INCREASED 61 0.0017
941 INCORRECT DRUG ADMINISTRATION DURATION 47 0.0017
942 LUNG NEOPLASM MALIGNANT 68 0.0017
943 PRESCRIBED UNDERDOSE 33 0.0017
944 SHOCK 38 0.0017
945 INJECTION SITE MASS 61 0.0016
946 SKIN IRRITATION 75 0.0016
947 MALIGNANT NEOPLASM PROGRESSION 167 0.0016
948 WRONG TECHNIQUE IN DRUG USAGE PROCESS 59 0.0016
949 BONE MARROW FAILURE 33 0.0016
950 OSTEONECROSIS OF JAW 39 0.0016
951 NEEDLE ISSUE 45 0.0015
952 NO ADVERSE EVENT 279 0.0015
953 GENERAL PHYSICAL HEALTH DETERIORATION 177 0.0015
954 MENORRHAGIA 30 0.0015
955 HEPATIC FAILURE 46 0.0015
956 PRODUCT PREPARATION ERROR 31 0.0015
957 MELAENA 33 0.0015
958 DEVICE MALFUNCTION 105 0.0015
959 NEOPLASM PROGRESSION 51 0.0015
960 OSTEONECROSIS 48 0.0015
961 EXTRAPYRAMIDAL DISORDER 36 0.0014
962 DEVICE DISLOCATION 59 0.0014
963 HEPATOTOXICITY 30 0.0013
964 RHABDOMYOLYSIS 55 0.0013
965 MENSTRUATION IRREGULAR 35 0.0013
966 DEVICE BREAKAGE 53 0.0013
967 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 44 0.0013
968 COLITIS ULCERATIVE 57 0.0013
969 DEATH 1096 0.0013
970 TREATMENT FAILURE 105 0.0013
971 INJECTION SITE HAEMORRHAGE 100 0.0013
972 DEVICE DELIVERY SYSTEM ISSUE 34 0.0012
973 CEREBRAL HAEMORRHAGE 43 0.0012
974 ADVERSE EVENT 109 0.0012
975 APPLICATION SITE ERYTHEMA 31 0.0012
976 DRUG EXPOSURE DURING PREGNANCY 40 0.0012
977 NEOPLASM MALIGNANT 78 0.0012
978 ACCIDENTAL EXPOSURE TO PRODUCT 118 0.0011
979 DEVICE LEAKAGE 48 0.0011
980 FOETAL EXPOSURE DURING PREGNANCY 89 0.0011
981 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 48 0.0010
982 INCORRECT ROUTE OF DRUG ADMINISTRATION 35 0.0010
983 DEVICE USE ERROR 33 0.0009
984 DRUG WITHDRAWAL SYNDROME 83 0.0009
985 BREAST CANCER 87 0.0009
986 PRODUCT ADHESION ISSUE 32 0.0009
987 PRODUCT STORAGE ERROR 62 0.0007
988 DRUG ABUSE 45 0.0005
989 DRUG DEPENDENCE 86 0.0005
990 DRUG DOSE OMISSION BY DEVICE 38 0.0005
991 DEVICE DIFFICULT TO USE 31 0.0005
992 PROSTATE CANCER 34 0.0004